Navigation Links
U.S. Hospital Sales Opportunities Maximized Through Functional Optimization
Date:8/15/2008

CHAPEL HILL, N.C., Aug. 15 /PRNewswire/ -- The U.S. hospital marketplace is multifaceted and can be divided into multiple market segments. In this challenging marketplace, pharmaceutical and biotechnology sales people must negotiate increasingly complex organizational and decision-making structures to effectively represent their brands. Hospital formulary decisions are not only being influenced by medical professionals focused on efficacy and safety but also by administrative personnel focused on operational efficiency and cost. Impactful benchmark research originally conducted by Best Practices, LLC in 2006 focused on understanding the variables in developing an effective sales force to service the hospital marketplace has been updated and published with comparisons drawn between current and historical data as appropriate.

In a benchmarking study that included such influential companies as Abbott, Astra Zeneca, Bayer, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Novartis, Pfizer, Procter & Gamble, Sanofi-Aventis, Schering-Plough, and Wyeth, key benchmark metrics and executive insights provide a basis for informing decision-making around critical structure, resource and process planning and execution.

For a complimentary summary of the full report "Sales Force Effectiveness: Benchmarking the Resources and Structure Required to Service the U.S. Hospital Marketplace," click on the following link http://www3.best-in-class.com/rr970.htm .

Key topic areas in the research include:

-- Targeting Key Decision Makers and Influencers

-- Hospital Sales Force Alignment, Structure and Support

-- Hospital Sales Force Training

-- GPO Focus

-- Lessons Learned

For more information on this report, contact Robert Naylor at rnaylor@best-in-class.com or (919) 767-9244. To access the full report or download a complimentary copy of the report summary
'/>"/>

SOURCE Best Practices, LLC
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Six UK Hospitals Join Together in Using Varian Medical Oncology Information Network
2. Largest Asian Cancer Hospital to Evaluate New CT Laser Breast Imaging System
3. Florida Childrens Hospital and Disney Unite to Create Magical Pediatric Hospital
4. Cooler Solutions and Leading Research Hospital to Design Revolutionary Osteoporosis Diagnosis Device
5. AG Mednet Selected By Massachusetts General Hospital to Transport 3D Post-Processing Images
6. National Surgical Hospitals Acquires Majority Share of Houston-Area Surgery Center
7. Candid Details on Hospitals Quality of Care Are Now at Your Fingertips - Just Like It Should Be
8. Anesiva Signs Co-Promotion and Distribution Agreement With Sagent Pharmaceuticals for Zingo(TM) in U.S. Hospitals
9. Chambersburg Hospital Streamlines Pharmacy Process and Increases Patient Safety With Omnicell WorkflowRx 5.0
10. American M.R.I.-DOL: Small Hospitals To Turn The Camera On Themselves In Unique National Contest
11. Hospitals Adopt STERIS Advanced Room Sterilization Technology in the Fight Against Superbugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... (PRWEB) March 29, 2015 A two-day ... United States and plenary talks by four leading photonics ... Optics + Optoelectronics next month in Prague, Czech ... in 17 conferences alongside a two-day exhibition. Sponsored by ... , the event will run 13-16 April in the ...
(Date:3/30/2015)... 2015 Richmond Pharmacology nimmt ... Pharmacology ist das erste Zentrum weltweit, das in ... Hospital in London in ... Studienversuche an einem Patienten begonnen hat. Das Therapeutikum ... entwickelt (ATTR), einer seltenen Herz- und Nervenkrankheit. ...
(Date:3/29/2015)... , March 29, 2015  Caris ... study data in small cell cervical cancer ... Caris Molecular Intelligence®, the company,s panomic, comprehensive ... gene mutations which may explain sensitivities and ... that identification of certain biomarkers may guide ...
(Date:3/27/2015)... Earlier this year, the Capillus272Pro™ received ... in adult men and women with androgenic alopecia (AGA) ... of IIa-V and Fitzpatrick Classification of Skin phototypes I-IV. ... over-promise and under-deliver, FDA Clearance underscores the safety and ... more than 80 million men and women who suffer ...
Breaking Biology Technology:Laser Energy Advances Among Reports Set for SPIE Optics + Optoelectronics 2Laser Energy Advances Among Reports Set for SPIE Optics + Optoelectronics 3Study Using Caris Molecular Intelligence Multiplatform Tumor Profiling Identifies Potential Treatment Strategies for Small Cell Cervical Cancer 2Study Using Caris Molecular Intelligence Multiplatform Tumor Profiling Identifies Potential Treatment Strategies for Small Cell Cervical Cancer 3Dr. Robert Leonard Applauds FDA Clearance of Capillus272Pro™ Hair Loss Laser Cap 2
... 3 Advanced Life Sciences,Holdings, Inc. (Nasdaq: ... development and commercialization of novel drugs in the,therapeutic ... it will present and participate in a panel ... Annual JPMorgan Healthcare Conference on January 9,2008., ...
... CEO to Provide Update on the Clinical and Commercial ... Axxent(R) ... Xoft, Inc., developer of the,Axxent(R) Electronic Brachytherapy System, a ... isotope-free,radiation therapy directly to cancer sites, today announced that ...
... to Manufacture; Genzyme will Continue to Market and ... ... and CAMBRIDGE, Mass., Jan. 3 ,BioMarin Pharmaceutical Inc. (Nasdaq and ... a restructuring of their joint venture,regarding Aldurazyme(R) (laronidase). Under the ...
Cached Biology Technology:Advanced Life Sciences to Present at Biodefense Session of 26th Annual JPMorgan Healthcare Conference 2Xoft to Present at the 26th Annual JPMorgan Healthcare Conference 2BioMarin and Genzyme Restructure Aldurazyme 50/50 Joint Venture 2BioMarin and Genzyme Restructure Aldurazyme 50/50 Joint Venture 3BioMarin and Genzyme Restructure Aldurazyme 50/50 Joint Venture 4BioMarin and Genzyme Restructure Aldurazyme 50/50 Joint Venture 5
(Date:3/23/2015)...  In the 2014 fiscal year, irs.gov recorded over ... figure accounts for a fraction of the estimated losses ... exceeds $11 billion globally. The polygraph has traditionally been ... occurred. Investor Mark Saint Juste along with ... partnered to administer the test in a new ...
(Date:3/20/2015)... 20, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... focused on the growing mobile commerce market, announces its ... of the products featured in 2015 "I Want That" ... PM EST on the DIY Network.   ... Vegas , site of the 2015 International CES ...
(Date:3/17/2015)... 2015 MedNet Solutions , a ... study management systems, is pleased to announce that ... Outsourcing in Clinical Trials Southeast conference – March ... excellent forum for MedNet to showcase iMedNet ... (SaaS) eClinical technology platform. We strongly ...
Breaking Biology News(10 mins):Polygraph Test Now Used to Protect Investors From Fraud 2Polygraph Test Now Used to Protect Investors From Fraud 3NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 2NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 3Connect With MedNet Solutions At Outsourcing In Clinical Trials Southeast 2
... from the University of Maryland and Beijing Normal University ... climate change internationally. When fully developed, the project ... for example, predict crop failure and changes in commodity ... At the University of Maryland today, officials from ...
... AMES, Iowa Genetic mutations to cellulose in plants could ... a research team that included two Iowa State University chemists. ... early edition of the Proceedings of the National Academy ... chemistry and an associate of the U.S. Department of Energy,s ...
... child,s cognitive development is not generally impacted by how ... according to a study from Nationwide Children,s Hospital. ... for the widest range of confounding factors when directly ... cognition. Insufficient or excessive weight gain in ...
Cached Biology News:UMD and Chinese partner to track and predict world climate change 2Iowa State, Ames Lab chemists aid study of mutated plants that may be better for biofuels 2Gestational weight gain generally does not influence child cognitive development 2
Immunogen: Synthetic peptide: N(171) H G F L S A D Q QL I K(183) Storage: -20 C, Avoid Freeze/Thaw Cycles...
The pCDF Expression System 1 plus Competent Cells contains 10 µg of pET-45b(+) DNA. pET-45b carries an N-terminal His•Tag ® coding sequence that is cleavable with enterokinase as well...
HIV-1 TAT (vN-21)...
Request Info...
Biology Products: